Experimental Alzheimer’s drug shows promise in small trial

An experimental Alzheimer’s drug from Eli Lilly showed significant slowing of decline in patients with early symptoms of the disease, the company said Monday.The results from a small clinical trial have not been published in a peer-reviewed journal…